ARMEN SHANAFELT
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
RONALD BERENSON, DANIEL CHEVALLARD, FRED DOTZLER, FREDERICK DOTZLER, BRYAN DUNNIVANT, STANDISH FLEMING, RICHARD GHALIE, PAUL GODDARD, MARK HANDFELT, MICHAEL HUANG, JOHN P. LONGENECKER, NAHEED MISFELDT, SAMUEL MURPHY, SUSAN PERRINE, ROGER POMERANTZ, WAYNE ROE, GUR ROSHWALB, IVOR ROYSTON, TAMARA SEYMOUR, BARRY SIMON, DAVID SLACK, PATRICK SOON-SHIONG, GEORGE STAMATOYANNOPOULOS, JAMES WOODY, JAMES N. WOODY
DIRECTOR
RONALD BERENSON, DANIEL CHEVALLARD, FRED DOTZLER, FREDERICK DOTZLER, BRYAN DUNNIVANT, STANDISH FLEMING, RICHARD GHALIE, PAUL GODDARD, MARK HANDFELT, MICHAEL HUANG, JOHN P. LONGENECKER, NAHEED MISFELDT, SAMUEL MURPHY, SUSAN PERRINE, ROGER POMERANTZ, WAYNE ROE, GUR ROSHWALB, IVOR ROYSTON, TAMARA SEYMOUR, BARRY SIMON, DAVID SLACK, PATRICK SOON-SHIONG, GEORGE STAMATOYANNOPOULOS, JAMES WOODY, JAMES N. WOODY
DIRECTOR
DIRECTOR
DIRECTOR
MANUEL AIVADO, MANUEL ALVES-AIVADO, M.D., PH.D., REINHARD J. AMBROS, MICHAEL DIEM, SUSAN L. DREXLER, WILLIAM FAIREY, BRIAN M. GALLAGHER, JR., SETH HARRISON, SETH L. HARRISON, SCOTT KAPNICK, JOHN H. MCARTHUR, CAMPBELL MURRAY, ALAN MUSSO, ENRICO PETRILLO, NOLAN SIGAL, M.D., PH.D., JOSEF H. VON RICKENBACH, CALEB WINDER, BRIAN WINDSOR, PH.D., JOSEPH A. YANCHIK III
DIRECTOR
DIRECTOR
JEFFREY W. ALBERS, JONATHAN ALSPAUGH, SCOTT BURROWS, CORTNEY CAUDILL, RUSSELL J. COX, GEORGE GEORGIOU, PETER HARWIN, MICHAEL HENDERSON, HEIDY KING-JONES, TOMAS KISELAK, ALISON LAWTON, DAVID G. LOWE, IVANA MAGOVCEVIC-LIEBISCH, HENRY SKINNER, HUNTER C, SMITH, LAURIE STELZER, CAMERON TURTLE, CHARLES N. YORK
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2018-05-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2018-05-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-12-23

